These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5887290)

  • 1. [Effects of portacaval shunt on gastric secretion in cirrhotic dogs].
    Storace R
    Chir Patol Sper; 1965; 13(5):178-82. PubMed ID: 5887290
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of portacaval shunting on gastric secretion in cirrhotic dogs.
    HEIN MF; SILEN W; SKILLMAN JJ; HARPER HA
    Gastroenterology; 1963 May; 44():637-41. PubMed ID: 13953414
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of experimental liver disease and portacaval shunts on gastric acid secretion and blood histamine.
    Windsor CW; Thompson JC; Orloff MJ
    Surg Forum; 1965; 16():322-4. PubMed ID: 5835175
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal and stimulated gastric secretion in man with cirrhosis with and without portacaval shunt.
    Alderman SJ; Keiter JE; Chandler JG; Rosen H; Orloff MJ
    Surg Forum; 1969; 20():363-5. PubMed ID: 5383088
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a monoamine oxidase inhibitor on blood ammonia and gastric secretion in dogs: II. Dogs with side-to-side and end-to-side portacaval anastomosis.
    Kowalewski K; Bondar GF
    Can J Surg; 1966 Jan; 9(1):99-103. PubMed ID: 5900272
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the problem of gastric juice secretion and gastroduodenal ulcer in portal hypertension in liver cirrhosis and after portercaval shunt operations].
    SCHRIEFERS KH; SCHREIBER HW; ESSER G
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963; 302():702-15. PubMed ID: 13987049
    [No Abstract]   [Full Text] [Related]  

  • 8. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt.
    Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H
    Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some observations on the cause of the gastric hypersecretion following portacaval shunt.
    McPhedran NT; Bett HD; Stone RM; Goldberg M
    Bull Soc Int Chir; 1968; 27(4):286-90. PubMed ID: 5714998
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in gastric secretion after portacaval shunting.
    Thompson JC
    Am J Surg; 1969 Jun; 117(6):854-65. PubMed ID: 5794868
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum gastrin-like activity following portacaval shunt in dogs.
    Wilken BJ; Hunt DG; Hardy JD
    Br J Surg; 1969 Sep; 56(9):695. PubMed ID: 5808390
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous origin of the humoral agent responsible for gastric hypersecretion associated with portacaval shunt.
    Villar-Valdes H; Thompson AG; Rosen H; Chandler JG; Orloff MJ
    Surg Forum; 1969; 20():360-2. PubMed ID: 5383087
    [No Abstract]   [Full Text] [Related]  

  • 13. [PEPTIC ULCER AND HEPATIC CIRRHOSIS].
    GONZALEZCAMPOS C
    Rev Esp Enferm Apar Dig Nutr; 1963; 22():842-8. PubMed ID: 14073235
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of arterialization of the liver on gastric secretion of dogs with portacaval shunts.
    NICOLOFF DM; DOBERNECK RC; LEONARD AS; PETER ET; WANGENSTEEN OH
    Am J Dig Dis; 1962 Nov; 7():1034-8. PubMed ID: 13938456
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of portacaval shunting on postprandial serum gastrin levels in dogs.
    Clendinnen BG; Reeder DD; Jackson BM; Miller JH; Thompson JC
    Surg Forum; 1970; 21():339-40. PubMed ID: 5514757
    [No Abstract]   [Full Text] [Related]  

  • 16. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z; Feng H; Leng X; Ma F; Wang B; Du R
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological changes in the stomach in portocaval anastomosis in dogs].
    Rudenskaia MV
    Eksp Khir Anesteziol; 1967; 12(2):34-8. PubMed ID: 5618922
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the site of origin of the agent causing hypersecretion in dogs with portacaval shunt.
    CLARKE JS; McKISSOCK PK; CRUZE K
    Surgery; 1959 Jul; 46(1):48-55. PubMed ID: 13668814
    [No Abstract]   [Full Text] [Related]  

  • 19. Nature of the gastric hypersecretion associated with intestinal exclusion.
    Villar H; Abbott AG; Williams RJ; Rosen H; Orloff MJ
    Surg Forum; 1971; 22():299-300. PubMed ID: 5121380
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastric secretion and peptic ulcer following portacaval shunt in man.
    Orloff MJ; Chandler JG; Alderman SJ; Keiter JE; Rosen H
    Ann Surg; 1969 Oct; 170(4):515-27. PubMed ID: 5344030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.